Genetically proxied antidiabetic drugs targets and stroke risk
Abstract Background Previous studies have assessed the association between antidiabetic drugs and stroke risk, but the results are inconsistent. Mendelian randomization (MR) was used to assess effects of antidiabetic drugs on stroke risk. Methods We selected blood glucose-lowering variants in genes...
Main Authors: | Yahui Zhu, Mao Li, Hongfen Wang, Fei Yang, Xinyuan Pang, Rongrong Du, Jinghong Zhang, Xusheng Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-04565-x |
Similar Items
-
Association of Antidiabetic Drug Target Genes with Inflammatory Bowel Disease: A Mendelian Randomization Study
by: Qing X, et al.
Published: (2024-02-01) -
Association between Genetically Proxied Inhibition of HMG-CoA Reductase and Age at Onset of Huntington’s Disease
by: Yahui Zhu, et al.
Published: (2022-11-01) -
The Impact of Genetically Proxied AMPK Activation, the Target of Metformin, on Functional Outcome Following Ischemic Stroke
by: Mengmeng Wang, et al.
Published: (2023-05-01) -
Antidiabetic medications and the risk of prostate cancer in patients with diabetes mellitus: A systematic review and meta-analysis
by: Haiying Cui, et al.
Published: (2022-03-01) -
Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study
by: Shuai Yuan, et al.
Published: (2021-04-01)